What Vital Cancer Drugs Are Facing The English Axe?

Thousands of cancer patients in the UK could lose access to vital medicines unless drastic changes are made. Currently, 25 drugs, deemed too expensive for the NHS (but available through the Cancer Drugs Fund) could be axed under new plans, including all six breast cancer drugs prescribed to thousands in three years. Read more here. (Source: MailOnline, 11/17/14).

You might also be interested in:

Report: NHS Failing to Treat Common Causes of Death June 26, 2018
Study: ICER Value Assessments Could Leave Medicare Part B… June 2, 2018
NICE Report: Cancer Drugs Priced According to Effectiveness… February 25, 2019
Gottlieb Says Insurers Must Take Risk on Biosimilars March 20, 2019
Time to Market: Accelerating Market Access January 4, 2019
Study: Moving Some Plans to Part D Could Cut Spending, but Not… January 17, 2019
Top 5 Signs You Are Ready for an Online Master’s Degree in… June 12, 2018